How does comorbidity influence survival in idiopathic pulmonary fibrosis?

Respiratory Medicine

Volumn 108, Issue 4, 2014, Pages 647-653

  Hyldgaard, Charlotte ^a   Hilberg, Ole ^a   Bendstrup, Elisabeth ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cardiovascular disease; Comorbidity; Diabetes; Idiopathic pulmonary fibrosis; Prognosis; Survival

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISOLONE; ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLADDER CANCER; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; DENMARK; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LUNG CANCER; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; OSTEOPOROSIS; OXYGEN THERAPY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; PULMONARY HYPERTENSION; RECTUM CANCER; SURVIVAL RATE; UNIVERSITY HOSPITAL; AGED; CARDIOVASCULAR DISEASES; EPIDEMIOLOGY; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN MEIER METHOD; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; ANTICOAGULANTS; CARDIOVASCULAR DISEASES; COMORBIDITY; DENMARK; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84896078055     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.01.008     Document Type: Article

References (31)

1. C. Hyldgaard, O. Hilberg, A. Muller, and E. Bendstrup A cohort study of interstitial lung diseases in central Denmark Respir Med 2013 10.1016/j.rmed.2013.09.002
2. G. Raghu, H.R. Collard, J.J. Egan, F.J. Martinez, J. Behr, and K.K. Brown et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 2011 788 824
3. B. Ley, C.J. Ryerson, E. Vittinghoff, J.H. Ryu, S. Tomassetti, and J.S. Lee et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis Ann Intern Med 156 2012 684 691
4. Danish National Board of Health. Danish Cancer Registry 2010.
5. H.R. Collard, A.J. Ward, S. Lanes, D. Cortney Hayflinger, D.M. Rosenberg, and E. Hunsche Burden of illness in idiopathic pulmonary fibrosis J Med Econ 15 2012 829 835
6. E.R. Fernandez Perez, C.E. Daniels, D.R. Schroeder, J. St Sauver, T.E. Hartman, and B.J. Bartholmai et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study Chest 137 2010 129 137
7. T. Enomoto, J. Usuki, A. Azuma, T. Nakagawa, and S. Kudoh Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis Chest 123 2003 2007 2011
8. M.C. Garcia-Sancho Figueroa, G. Carrillo, R. Perez-Padilla, M.R. Fernandez-Plata, I. Buendia-Roldan, and M.H. Vargas et al. Risk factors for idiopathic pulmonary fibrosis in a Mexican population. A case-control study Respir Med 104 2010 305 309
9. L. Richeldi, H.R. Davies, G. Ferrara, and F. Franco Corticosteroids for idiopathic pulmonary fibrosis Cochrane Database Syst Rev 3 2003 CD002880
10. A. Ponnuswamy, R. Manikandan, A. Sabetpour, I.M. Keeping, and J.P. Finnerty Association between ischaemic heart disease and interstitial lung disease: a case-control study Respir Med 103 2009 503 507
11. R.M. du Bois, D. Weycker, C. Albera, W.Z. Bradford, U. Costabel, and A. Kartashov et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 184 2011 459 466
12. D.M. Mannino, D. Thorn, A. Swensen, and F. Holguin Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Eur Respir J 32 2008 962 969
13. N.R. Anthonisen, J.E. Connett, P.L. Enright, J. Manfreda, and Lung Health Study Research Group Hospitalizations and mortality in the Lung Health Study Am J Respir Crit Care Med 166 2002 333 339
14. S.D. Nathan, A. Basavaraj, C. Reichner, O.A. Shlobin, S. Ahmad, and J. Kiernan et al. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis Respir Med 104 2010 1035 1041
15. Y. Ozawa, T. Suda, T. Naito, N. Enomoto, D. Hashimoto, and T. Fujisawa et al. Cumulative incidence of and predictive factors for lung cancer in IPF Respirology 14 2009 723 728
16. K. Hamada, S. Nagai, S. Tanaka, T. Handa, M. Shigematsu, and T. Nagao et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis Chest 131 2007 650 656
17. I. Le Jeune, J. Gribbin, J. West, C. Smith, P. Cullinan, and R. Hubbard The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK Respir Med 101 2007 2534 2540
18. J.M. Harris, I.D. Johnston, R. Rudd, A.J. Taylor, and P. Cullinan Cryptogenic fibrosing alveolitis and lung cancer: the BTS study Thorax 65 2010 70 76
19. C.J. Ryerson, P.A. Arean, J. Berkeley, V.L. Carrieri-Kohlman, S.Z. Pantilat, and C.S. Landefeld et al. Depression is a common and chronic comorbidity in patients with interstitial lung disease Respirology 17 2012 525 532
20. C.J. Ryerson, J. Berkeley, V.L. Carrieri-Kohlman, S.Z. Pantilat, C.S. Landefeld, and H.R. Collard Depression and functional status are strongly associated with dyspnea in interstitial lung disease Chest 139 2011 609 616
21. J. De Vries, B.L. Kessels, and M. Drent Quality of life of idiopathic pulmonary fibrosis patients Eur Respir J 17 2001 954 961
22. N. Tzanakis, M. Samiou, I. Lambiri, K. Antoniou, N. Siafakas, and D. Bouros Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests Eur J Intern Med 16 2005 105 112
23. C.U. Andersen, S. Mellemkjaer, O. Hilberg, J.E. Nielsen-Kudsk, U. Simonsen, and E. Bendstrup Pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test Respir Med 106 2012 875 882
24. C.J. Lettieri, S.D. Nathan, S.D. Barnett, S. Ahmad, and A.F. Shorr Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis Chest 129 2006 746 752
25. I. Noth, K.J. Anstrom, S.B. Calvert, J. de Andrade, K.R. Flaherty, and C. Glazer et al. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 186 2012 88 95
26. J.S. Lee, J.H. Ryu, B.M. Elicker, C.P. Lydell, K.D. Jones, and P.J. Wolters et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 184 2011 1390 1394
27. S. Tomassetti, J.H. Ruy, and C. Gurioli Et Al The effect of anticoagulant therapy for idiopathic pulmonary fibrosis in real life practice Sarcoidosis Vasc Diffuse Lung Dis 30 2013 121 127
28. J. Lee, H. Collard, K. Anstrom, F. Martinez, I. Noth, and R. Roberts et al. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials Lancet Respir Med 1 2013 369 376
29. A.U. Wells, S.R. Desai, M.B. Rubens, N.S. Goh, D. Cramer, and A.G. Nicholson et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography Am J Respir Crit Care Med 167 2003 962 969
30. M. Divo, C. Cote, J.P. de Torres, C. Casanova, J.M. Marin, and V. Pinto-Plata et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 186 2012 155 161
31. B.R. Celli, C.G. Cote, J.M. Marin, C. Casanova, M. Montes de Oca, and R.A. Mendez et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 2004 1005 1012